S&P 500 Futures
(-0.61%) 5 076.50 points
Dow Jones Futures
(-0.36%) 38 540 points
Nasdaq Futures
(-0.94%) 17 499 points
Oil
(-0.04%) $82.78
Gas
(-0.42%) $1.646
Gold
(-0.03%) $2 337.60
Silver
(0.14%) $27.39
Platinum
(0.07%) $916.40
USD/EUR
(-0.25%) $0.932
USD/NOK
(-0.35%) $10.94
USD/GBP
(-0.45%) $0.799
USD/RUB
(-0.20%) $92.14

Realtime updates for Xeris Pharmaceuticals Inc [XERS]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
100.00%
return 20.02%
SELL
25.00%
return 5.41%
Last Updated24 Apr 2024 @ 16:00

-1.12% $ 1.760

SELL 101994 min ago

@ $2.97

Issued: 14 Feb 2024 @ 09:30


Return: -40.72%


Previous signal: Feb 13 - 12:28


Previous signal: Buy


Return: 2.92 %

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 16:00):
Profile picture for Xeris Pharmaceuticals Inc

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology...

Stats
Today's Volume 694 220
Average Volume 1.92M
Market Cap 247.20M
EPS $0 ( 2024-03-06 )
Next earnings date ( $-0.120 ) 2024-05-14
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -3.91
ATR14 $0.00600 (0.34%)
Insider Trading
Date Person Action Amount type
2024-03-15 Sherman Jeffrey W Buy 6 502 Common Stock
2024-03-15 Kong Garheng Buy 6 474 Common Stock
2024-03-15 Johnson John Buy 89 571 Common Stock
2024-03-18 Johnson John Buy 215 600 Common Stock
2024-03-18 Johnson John Sell 215 600 Stock Option (Right to Buy)
INSIDER POWER
92.72
Last 99 transactions
Buy: 12 203 668 | Sell: 238 056

Volume Correlation

Long: -0.17 (neutral)
Short: 0.83 (strong)
Signal:(55.008) Same movement expected

Xeris Pharmaceuticals Inc Correlation

10 Most Positive Correlations
MTSL0.806
DBDR0.802
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Xeris Pharmaceuticals Inc Correlation - Currency/Commodity

The country flag 0.43
( neutral )
The country flag 0.19
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.76
( moderate )
The country flag 0.10
( neutral )

Xeris Pharmaceuticals Inc Financials

Annual 2024
Revenue: $163.91M
Gross Profit: $124.43M (75.91 %)
EPS: $-0.450
Q2 2024
Revenue: $44.39M
Gross Profit: $34.11M (76.84 %)
EPS: $-0.0969
Q1 2024
Revenue: $48.32M
Gross Profit: $40.12M (83.03 %)
EPS: $-0.0883
Q4 2023
Revenue: $38.01M
Gross Profit: $30.45M (80.12 %)
EPS: $-0.140

Financial Reports:

No articles found.

Xeris Pharmaceuticals Inc

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators